FAM83B is a novel biomarker for diagnosis and prognosis of lung squamous cell carcinoma

Personalized therapy for non-small cell lung cancer (NSCLC), particularly lung adenocarcinoma, has recently been significantly improved by the discovery of various molecular targets. However, this has not been the case for lung squamous cell carcinoma (SCC). In the present study, we identified the f...

Descripción completa

Detalles Bibliográficos
Autores principales: OKABE, NAOYUKI, EZAKI, JUNJI, YAMAURA, TAKUMI, MUTO, SATOSHI, OSUGI, JUN, TAMURA, HIROSUMI, IMAI, JUN-ICHI, ITO, EMI, YANAGISAWA, YUKA, HONMA, REIKO, GOTOH, MITSUKAZU, WATANABE, SHINYA, WAGURI, SATOSHI, SUZUKI, HIROYUKI
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324586/
https://www.ncbi.nlm.nih.gov/pubmed/25586059
http://dx.doi.org/10.3892/ijo.2015.2817

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324586/
https://www.ncbi.nlm.nih.gov/pubmed/25586059
http://dx.doi.org/10.3892/ijo.2015.2817

Ejemplares similares